Leadless Pacemaker
Kessels, S, Parsons, J, Ellery, B
Record ID 32018000695
English
Authors' results and conclusions:
Evidence for the safety and effectiveness of leadless pacemakers is limited. Only one small study in humans has been finalised and the other trials assessing procedural and safety outcomes in patients indicated for single chamber ventricular pacing are still ongoing. It is not known if there are differences in effectiveness and safety when comparing the two devices (Nanostim and Micra). Data on the long term effectiveness and risk of complications, e.g. spontaneous dislodgement and embolisation, is lacking and should be investigated.
Authors' recommendations:
HealthPACT noted that this technology as the potential to reduce side effects and adverse events compared to pacemakers currently in use. Leadless pacemakers are, however, significantly more expensive in comparison to conventional single chamber pacemakers ($16,000 vs $6,000), which may limit their potential diffusion and uptake in clinical practice in Australia and New Zealand. HealthPACT does not support investment in this technology in clinical practice at this time; however, it is recommended that the evidence be reviewed again in 24 months.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
Not Available
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Pacemaker, Artificial
- Equipment Design
- Prostheses and Implants
Contact
Organisation Name:
Adelaide Health Technology Assessment
Contact Address:
School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name:
ahta@adelaide.edu.au
Contact Email:
ahta@adelaide.edu.au
Copyright:
Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.